etiocholanolone has been researched along with cardiovascular agents in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashley, EA; deGoma, EM; Fowler, MB; Vagelos, RH | 1 |
| Bilińska, ZT; Skóra, E | 1 |
| Böhm, M; De Luca, L; Dickstein, K; El-Banayosy, A; Filippatos, G; Gheorghiade, M; Mebazaa, A; Nieminen, M; Parissis, JT; Rhodes, A; Voors, AA; Zannad, F | 1 |
| Bianchetti, M; Blair, JE; Bubenek-Turconi, SI; Carminati, P; Ceracchi, M; Filippatos, GS; Gheorghiade, M; Grzybowski, J; Korewicki, J; Kremastinos, D; Macarie, C; Ruzyllo, W; Sabbah, HN; Shah, SJ; Valentini, G | 1 |
3 review(s) available for etiocholanolone and cardiovascular agents
| Article | Year |
|---|---|
Emerging therapies for the management of decompensated heart failure: from bench to bedside.
Topics: Antidiuretic Hormone Receptor Antagonists; Atrial Natriuretic Factor; Cardiac Myosins; Cardiotonic Agents; Cardiovascular Agents; Etiocholanolone; Heart Failure; Humans; Natriuretic Agents; Peptide Fragments; Perhexiline; Purinergic P1 Receptor Antagonists; Sodium-Potassium-Exchanging ATPase | 2006 |
[New therapeutic goals--new drugs in heart failure treatment].
Topics: Amides; Cardiovascular Agents; Etiocholanolone; Fumarates; Heart Failure; Humans; Neovascularization, Physiologic; Ventricular Remodeling | 2007 |
Overview of emerging pharmacologic agents for acute heart failure syndromes.
Topics: Adenosine; Cardiovascular Agents; Endothelin-1; Etiocholanolone; Heart Failure; Hemodynamics; Humans; Hydrazones; Natriuretic Peptide, Brain; Perhexiline; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Sodium-Potassium-Exchanging ATPase; Syndrome; Vasodilator Agents | 2008 |
1 trial(s) available for etiocholanolone and cardiovascular agents
| Article | Year |
|---|---|
Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in P
Topics: Acute Disease; Aged; Cardiovascular Agents; Diastole; Etiocholanolone; Female; Heart; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Sodium-Potassium-Exchanging ATPase; Stroke Volume | 2009 |